纵横研报
Ticker Detail

600211.SHG

¥40.07+1.96% 西藏药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Tibet Rhodiola Pharmaceutical Holding Co
医疗健康 · 专科与仿制药

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.

MARKET 市值 12.49B CNY PE 12.9x Fwd 135.1x 52W ¥34.8 – ¥57.98 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY 1.6% ROE 22.2% 营业利润率 29.7% 净利润率 32.3%
ANALYST 股息率 4.62%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制